Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzo Biochem Inc (NYSE:ENZ)

5.63
Delayed Data
As of Aug 24
 -0.16 / -2.76%
Today’s Change
2.57
Today|||52-Week Range
7.00
+25.11%
Year-to-Date
No recent news for Enzo Biochem Inc.

Today’s Trading

Previous close5.79
Today’s open5.75
Day’s range5.58 - 5.79
Volume100,892
Average volume (3 months)281,924
Market cap$267.9M
Dividend yield--
Data as of 08/24/2016

Growth & Valuation

Earnings growth (last year)+78.26%
Earnings growth (this year)+23.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+1.72%
P/E ratio14.8
Price/Sales1.39
Price/Book6.26

Competitors

 Today’s
change
Today’s
% change
BSTCBiospecifics Technol...-1.87-4.87%
NVIVInVivo Therapeutics ...-0.25-3.30%
RGNXRegenxbio Inc-0.33-2.49%
SNMXSenomyx Inc-0.01-0.26%
Data as of 08/24/2016

Financials

Next reporting dateOctober 11, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$97.6M
Annual profit (last year)-$2.3M
Net profit margin-2.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer, Director &
CAO
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs